Avid Bioservices, Inc. (CDMO)
NASDAQ: CDMO · Real-Time Price · USD
12.30
-0.03 (-0.24%)
At close: Dec 20, 2024, 4:00 PM
12.27
-0.03 (-0.24%)
After-hours: Dec 20, 2024, 6:27 PM EST
Avid Bioservices Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Avid Bioservices stock have an average target of 12.25, with a low estimate of 12 and a high estimate of 12.5. The average target predicts a decrease of -0.41% from the current stock price of 12.30.
Analyst Consensus: Hold
* Price targets were last updated on Nov 7, 2024.
Analyst Ratings
The average analyst rating for CDMO stock from 3 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
Buy | 3 | 3 | 3 | 3 | 2 | 1 |
Hold | 1 | 1 | 1 | 1 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 5 | 5 | 5 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Buy → Hold Downgrades $12 → $13 | Buy → Hold | Downgrades | $12 → $13 | +1.63% | Nov 7, 2024 |
William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 7, 2024 |
RBC Capital | RBC Capital | Buy Maintains $8 → $12 | Buy | Maintains | $8 → $12 | -2.44% | Sep 10, 2024 |
Stephens & Co. | Stephens & Co. | Buy Reiterates $12 | Buy | Reiterates | $12 | -2.44% | Sep 10, 2024 |
William Blair | William Blair | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 10, 2024 |
Financial Forecast
Revenue This Year
166.56M
from 139.91M
Increased by 19.05%
Revenue Next Year
201.33M
from 166.56M
Increased by 20.88%
EPS This Year
-0.30
from -2.23
EPS Next Year
-0.07
from -0.30
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 172.3M | 236.3M | 253.1M | ||
Avg | 166.6M | 201.3M | 234.9M | ||
Low | 159.0M | 180.9M | 212.2M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 23.2% | 41.8% | 25.7% | ||
Avg | 19.0% | 20.9% | 16.7% | ||
Low | 13.6% | 8.6% | 5.4% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -0.26 | 0.12 | 0.15 |
Avg | -0.30 | -0.07 | 0.14 |
Low | -0.34 | -0.21 | 0.14 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.